Ageronix

Ageronix is a privately held pharmaceutical company based in Geneva, Switzerland. With the innovative use of Alpha 1 Anti-trypsin, Ageronix stands at the forefront of neurodegenerative disease research. They aim to provide meaningful improvement to the quality of life for CMT1A patients, by not only slowing down the progression of the disease but ultimately reversing it.